Trimebutine API Manufacturers
compare suppliers & get competitive offers
Filters
Reset
Selected filters:
Type
Production region
Qualifications
Country of origin
Follow us
Distributor
We can develop new APIs upon request
GMP, EMA/FDA, OSHAS cert. CDMO
12 local offices, strategically around the world
+ 0
All certificates
Replies quickly
Producer
+ 0
All certificates
Replies slower than most
Producer
+ 0
All certificates
Replies slower than most
Producer
+ 0
All certificates
Replies slower than most
Producer
+ 0
All certificates
Replies slower than most
Producer
+ 0
All certificates
Replies slower than most
Replies slower than most
Producer
+ 0
All certificates
Not active
Distributor
+ 0
All certificates
Not active
Not active
How does it work?
You can register for free as long as you are registering on behalf of a legal company related to the pharmaceutical industry
Search in the search bar the product that you’re looking for. We’ll show you an overview of all available suppliers. Use the filters to select the relevant suppliers only
Have you found interesting suppliers? Then it’s time to contact them. Use the send inquiry button and send them a message. You can send for each product, 3 inquiries per week
Suppliers get notified by Pharmaoffer that they’ve received a new inquiry. They will come back to you with their questions, certificates, and offer in the chat on Pharmaoffer. We will send you an email in case of any news
Does the supplier meet your quality and commercial requirements? Then you can place the order. Just follow the steps of our order module
Looking for Trimebutine API 39133-31-8?
- Description:
- Here you will find a list of producers, manufacturers and traders of Trimebutine. You can sort by certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.
- API | Excipient name:
- Trimebutine
- Synonyms:
- Trimebutine maleate
- Cas Number:
- 39133-31-8
- DrugBank number:
- DB09089
- Unique Ingredient Identifier:
- QZ1OJ92E5R
About Trimebutine
Do you want to know more about Trimebutine? You can find a small explanation about it here. Trimebutine is a spasmolytic agent that regulates intestinal and colonic motility and relieves abdominal pain with antimuscarinic and weak mu opioid agonist effects. It is marketed for the treatment of irritable bowel syndrome (IBS) and lower gastrointestinal tract motility disorders, with IBS being one of the most common multifactorial GI disorders It is used to restore normal bowel function and is commonly present in pharmaceutical mixtures as trimebutine maleate salt form. Trimebutine is not a FDA-approved drug, but it is available in Canada and several other international countries.
Not sure if this is the exact product you're looking for? Contact the supplier by using the send inquiry button.
Trimebutine is a type of Motility inhibitors
Motility inhibitors are a subcategory of pharmaceutical active pharmaceutical ingredients (APIs) that are used to regulate and control the movement of the gastrointestinal tract. These inhibitors play a crucial role in treating conditions such as irritable bowel syndrome (IBS), gastroesophageal reflux disease (GERD), and other gastrointestinal disorders.
Motility inhibitors work by blocking the action of certain neurotransmitters and receptors in the gastrointestinal tract, thereby reducing the frequency and intensity of contractions in the smooth muscles. This leads to a decrease in the speed of food passage through the digestive system, providing relief from symptoms like abdominal pain, bloating, and diarrhea.
One commonly used motility inhibitor is metoclopramide, which acts by inhibiting dopamine receptors in the gastrointestinal tract. It enhances the contractions of the stomach and small intestine while relaxing the muscles of the pyloric sphincter, thus improving gastric emptying and reducing reflux.
Another important motility inhibitor is loperamide, which works by slowing down the muscular contractions of the intestines. It is commonly used to treat diarrhea by increasing the time it takes for stool to move through the digestive system.
Motility inhibitors are available in various forms, including tablets, capsules, and oral suspensions. They are generally well-tolerated, but like any medication, they can have side effects such as drowsiness, dizziness, and constipation.
In summary, motility inhibitors are an essential subcategory of pharmaceutical APIs used to manage gastrointestinal disorders by regulating the movement of the digestive tract. They provide relief from symptoms and improve overall digestive function, enhancing the quality of life for individuals suffering from these conditions.
Trimebutine (Motility inhibitors), classified under Gastrointestinal Agents
Gastrointestinal Agents belong to the pharmaceutical API category that focuses on treating disorders and ailments related to the digestive system. These agents play a crucial role in addressing various gastrointestinal conditions, such as acid reflux, ulcers, irritable bowel syndrome (IBS), and inflammatory bowel disease (IBD).
One of the key types of gastrointestinal agents is proton pump inhibitors (PPIs), which work by reducing the production of stomach acid. PPIs help in treating conditions like gastroesophageal reflux disease (GERD) and peptic ulcers. Another essential class of agents is antacids, which neutralize excessive stomach acid, providing relief from heartburn and indigestion.
Gastrointestinal agents also include antispasmodics that alleviate abdominal cramps and spasms associated with conditions like IBS. These drugs work by relaxing the smooth muscles of the digestive tract. Additionally, there are drugs categorized as laxatives that aid in relieving constipation by promoting bowel movements.
Moreover, certain gastrointestinal agents act as antiemetics, effectively reducing nausea and vomiting. These drugs are particularly useful for patients undergoing chemotherapy or experiencing motion sickness.
Pharmaceutical companies develop and manufacture a wide range of gastrointestinal agents in various forms, including tablets, capsules, suspensions, and injections. These agents are typically formulated using active pharmaceutical ingredients (APIs) and other excipients to ensure their efficacy and safety.
In conclusion, gastrointestinal agents form a vital category of pharmaceutical APIs, providing relief from digestive disorders and improving overall gastrointestinal health. The availability of diverse agents catering to different conditions ensures that patients can receive targeted treatment for their specific gastrointestinal needs.
Trimebutine manufacturers | traders | suppliers
We have 10 companies offering Trimebutine produced in 6 different countries.
Get in contact with the supplier of your choice:
- Suanfarma from Spain, product country of origin European Union
- Shiratori Pharmaceutical from Japan, product country of origin Japan
- Zhejiang East-Asia Pharma from China, product country of origin China
- PMC Isochem from France, product country of origin France
- Zhejiang East Asia Pharmaceutical from China, product country of origin China
- Sumitomo Chemical from Japan, product country of origin Japan
- Isochem from France, product country of origin France
- Edmond Pharma (Recipharm) from Italy, product country of origin Italy
- Shaoxing Hantai Pharma from China, product country of origin China
- Moehs from Spain, product country of origin Spain
Let the supplier know whether you are looking for a product with a specific monograph such as EP (Ph. Eur.), USP, JP, BP or another quality. Or, whether you are looking for hydrochloride (HCl), anhydricum, base, micronisatum or a specific purity.
You can use the filters to find high-quality suppliers. For example, you can select GMP, FDA or ISO certified suppliers. Visit our FAQ page or use the chat box in the corner to get more information about Pharmaoffer.
